Clinical Trials
4 trialsNCT05853458 2026-04-30
HU-F-AIM
Novartis
Phase 4 Terminated
NCT06063317 2026-03-06
OASIS
Imugene Limited
Phase 1 Terminated
NCT03860844 2025-09-09
ISAKIDS
Sanofi
Phase 2 Terminated
NCT00290771 2011-05-16
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Novartis
Phase 2 Terminated